We are thrilled to announce that Clark Lagemann, CEO of Avidon Health, has been featured in the June 2024 edition of HR.com’s Employee Benefits and Wellness Excellence magazine. His article, “GLP-1 Medications In Employee Health: Financial Implications And Best Practices,” dives deep into the hidden costs and opportunities of GLP-1 medications in corporate wellness programs.
In this insightful piece, Clark explores:
- Understanding GLP-1 Agonists: The revolutionary impact of GLP-1 medications on weight loss and the substantial financial implications for employers.
- The Cost to Employers: Detailed analysis of the long-term healthcare costs associated with these medications, highlighting the importance of chronic use for sustained results.
- Challenges in Adherence: Examination of the low real-world adherence rates and the necessity of consistent use to maintain health benefits.
- The Role of Health Coaching: The critical role of integrating health coaching with GLP-1 therapy to achieve sustainable weight loss and health improvements.
- Recommendations for HR Decision-Makers: Practical strategies for evaluating the cost-benefit, promoting adherence, integrating health coaching, monitoring outcomes, and fostering a supportive environment.
This contribution underscores our commitment to advancing employee wellness and providing valuable insights to HR professionals navigating the complexities of modern healthcare trends.
